Chapter 75: Care of Male Patients with Reproductive Problems Flashcards
Benign Prostatic Hypertrophy/Hyperplasia
Age associated enlargement of the prostate gland in men, may cause bladder compression and constrict urinary flow.
The patient will have increased residual urine or acute urinary retention. This may result in overflow urinary incontinence which urine links and dribbles. They can also cause urinary tract infection and bladder stones. Urine retention can lead to chronic kidney disease. Assess for bladder outlet obstruction and lower urinary tract symptoms. LUTS. Assess from hematuria.
Prostate exam: BPH is uniform, elastic, nontender enlargement. Cancer will feel stony hard. May massage it for a fluid sample to rule out prosatitis.
hyperplasia vs hypertrophy
hyperplasia-increase in CELLS
hypertrophy-enlargment
LUTS lower urinary tract symptoms
Difficulty in starting and continuing urination.
Reduced force and size of the urinary stream.
Sensation of incomplete bladder emptying.
Post void dribbling.
Lab work for BPH
Urinalysis and culture to evaluate UTI and hematuria
CBC for systemic infection or anemia
BUN and creatnine to evaluate renal function
PSA and serum acid phosphatase if cancer is suspected
Culture of prostatic fluid
Prostate ultrasound
Tissue biopsy
Cytoscope to view bladder
Bladder ultrasound to check for residual urine
Key features of BPH
Urinary frequency
Nocturia
Urinary hesitancy, difficulty starting the stream
Hematuria
Diminished force of the stream
Dribble post voiding
Bladder distention
Renal insufficiency: edema, pallor, pruritus
Uniform, elastic, nontender, palpable prostate
Nursing DX BPH
Urinary retention related to blockage from the enlarged prostate. Urinary incontinence related to over distention of the bladder. Disturbed sleep pattern related to nocturia.
Risk for infection related to residual urine.
Potential for renal insufficiency or chronic kidney disease.
Nonsurgical Treatment for BPH
5-alpha reductase inhibitor such as Proscar-finasteride or Avodart-dutasteride. They lower the DHT (testosterone) which can shrink the prostate and prevent further growth. May need six months before improvement. Side effects include erectile dysfunction and decreased libido
Alpha blocking agents such as tamsulsin/Flomax and alfuzosin/Uroxatral. These cause the prostrate gland to constrict reducing urethral pressure and improving urine flow. Alpha blockers such as Cardura and Hytrin are used to treat if hypertension is present. Assess for orthostatic hypotension and syncope. Bedtime dosing may decrease the risk for hypertension. Erectile dysfunction drugs can worsen the side effects. These drugs can cause liver dysfunction
CAM: saw palmetto extract and lycopene(in tomatoes)
Other: Frequent intercourse helps release prostatic fluid. Teach to avoid drinking large amounts of fluid in a short time, avoid alcohol, diuretics, and caffeinr; void as soon as he feel the urge. Avoid medications that cause urinary retention such as anticholinergics, antihistamines, and decongestants.
Thermotherapy
TUNA: transurethral needle ablation. Low radiofrequency energy shrinks the prostate
TUMT:transurethral microwave therapy. High temperatures heat and destroy excess tissue
ILC: interstitial laser coagulation. Laser energy coagulates excess tissue
Electrovaporization: High-frequency electrical current cuts and vaporizes excess tissues
Prostatic stent
Surgical treatment for BPH
TURP: transurethral resection of the prostate
Possible open prostatectomy
Criteria for surgery: Acute urinary retention. Chronic urinary tract infections secondary to residual urine. Hematuria. Hydronephrosis.
Usually epidural or spinal. This allows for assessment of hyponatremia which can occur from fluid overload, water intoxication from bladder irrigation. Catheter will be present for at least a day and they will feel the urge to avoid. The patient will probably have continuous bladder irrigation and traction on the catheter that may cause discomfort. Urine will be bloody with some small clots. The surgery is performed using a rectoscope through the urethra and removes the enlarged portion. Fibrinolytic may be used to prevent excess clotting.
Disadvantages include re-enlargement of the prostate, urinary urethral strictures.
Once the catheter is removed the patient may experience burning and frequency, dribbling, which are normal and will decrease. Small clots will be passed for several days. Increased fluid intake to 2000 - 2500 mL. Watch for complications such as infection and incontinence. Sexual function should not be affected but retrograde ejaculation is possible. Monitor urine output every two hours.
Assess bleeding:
Arterial bleed: urinary drainage is bright red or ketchup like with numerous clots. Notify the surgeon immediately and increase irrigation. Surgical intervention maybe needed.
Venous bleed: urine output is burgundy with out vital sign changes. Inform the surgeon. May possibly apply traction on the catheter and prescribed analgesics or anti-spasmodics. Monitor the H&H.
Encourage mobility but watch for fall risk. Anticipate mental status change. Reorient frequently. Use normal saline for bladder irrigation. Check tubing frequently.
Prostate cancer
Most common type of cancer in men in the US. Second-leading cause of death. DHT is in the prostate gland and causes it to grow very rapidly leading to noncancerous high-grade prosthetic intraepithelial neoplasia. HGPIN. They are higher risk for cancer.
The cancer is slow-growing and metastasis to the nearby lymph nodes, bones, lungs, and liver.
Blood in the urine is the most common clinical manifestation. Check for swollen lymph nodes. Unexpected weight loss is common. The prostate will be stony heart and irregular.
Risk factors for prostate cancer
Low if castrated before puberty. Advancing age. Men older than 65 are at greatest risk. Diet high in animal fat. Viruses, family history, vitamin D and E deficiencies, genetics, exposure to environmental toxins. In the US it affects African men most and at an earlier age.
Prostate screening
Annual digital rectal exam and PSA test to men beginning at age 50,
men who have a life expectancy of at least 10 years,
African men beginning at age 45, men with one in family at 45
Age 40 if 2 or more in family
Abnormal PSA is above 4.0
Promotion: Decrease animal fats and redmeat. Eat more fish and omega-3 fatty acids. Increase fruits and vegetables. Tomatoes, watermelon, grapefruit, papaya, broccoli, cauliflower, cabbage, kale. Other foods include selenium, vitamin D, catechin found in green tea. Exercise. Do not get too much calcium. Tobacco and alcohol increase growth.
Tests for prostate cancer
PSA (normal is 4 or under) with DRE. Draw the PSA before the exam.
EPCA-2
Ultrasound TRUS: Complications include humanity urea with clots, infection, perineal pain. Report fever, chills, bloody urine, difficulty voiding. Avoid physical activity and drink plenty of fluids for 24 hours.
Biopsy
Cancer is determined, more tests are done.
Lymphnode biopsy, CT of pelvis and abdomen, MRI, bone scan, liver functions, serum phosphatase
Nursing diagnosis for prostate cancer
Impaired urinary elimination related to urinary tract infections caused by bladder outlet obstruction.
Anxiety and fear.
Acute or chronic pain.
Risk for sexual dysfunction.
Dysfunctional grieving or anticipatory grieving.
Potential for metastasis
Surgical Treatment for prostate cancer
Usually treatment is 10 years after diagnosis because of its slow growing. Surgery for a cure is a prostatectomy. Bilateral orchiectomy which is removal of both testicals helps slow the growth of cancer.
Advantages of LRP-laparascopic radcial prostatectomy:
To qualify PSA must be under 10, never had hormone therapy or abdominal surgery. Decreased hospital stay, minimal bleeding, smaller incisions, less pain, decreased catheter time, fewer complications, faster recovery, nerve sparing advantages. Resume activities in about a week
Open: The patient will be sterile and have retrograde ejaculation. Temporary erectile dysfunction may last for 3 to 18 months. Resume activities in about 3-5 weeks. Potential long-term complications include urinary incontinence and erectile dysfunction. Keagle exercises may help. Teach exercises such as tightening the perennial muscles for 3 to 5 seconds and then relax. Bear down as if having a bowel movement and relax.
Post operative care after an open prostatectomy
Use a PCA pump.
Ambulate the night of surgery.
Wear SCDs.
Monitor for DVT.
Intake and output including drainage devices.
Keep urinary meatus clean using soap and water.
Avoid rectal procedures or treatments
Teach the patient how to care for the catheter which will be in place for 7 to 14 days.
Teach the patient how to use a leg bag.
Do not strain during bowel movements. Avoid suppositories and enemas. Possible stool softener
Follow-up appointments
Lift no more than 15 pounds for six weeks. Do not walk bent over. Vigorous exercise avoided for 12 weeks. Shower for 2 to 3 weeks and do not bathe.
May have peyronie’s disease
Hormone therapy for prostate cancer
Radiation therapy: is an alternative curative treatment to surgery for locally contain tumors, an adjunct to radical prostatectomy when lymph nodes show cancer, palliation of the patient’s symptoms.
External beam: 5 days a week for 6-9 weeks. Usually causes ED. Acute radiation cystitis which is persistent pain and hematuria, and usually goes away in 6 weeks. Avoid caffeine and increase water
Radiation proctitis: rectal mucosa inflammation which includes rectal urgency and cramping, passes mucous and blood. Goes away in 4-6 weeks. Avoid spicy, fatty, caffeine, and dairy.
Internal radiation/brachytherapy: implants low dose seeds. Not harmful. ED, incontinence and rectal problems are small. Fatigue for several months.
Drug therapy:
ADT: androgen deprivation therapy can be done by B-orchiectomy, and-or luteinizing hormone-releaseing hormone agonists or antiandrogens.
LH agonists stimulate the pituitary gland to release LH which it runs out of in about three weeks. This then reduces testosterone production. Side effects include hot flashes, erectile dysfunction, and decreased libido. Some will also get gynecomastia, and osteoporosis.
Anti-androgens block the bodys ability to use androgens. These are used when there is metastatic disease. They inhibit tumor progression by blocking the uptake of testicular and adrenal androgen at the prostate tumor site. They may be used in combination with LH agonists.